{"id":94226,"date":"2013-10-30T10:54:30","date_gmt":"2013-10-30T14:54:30","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/bg-medicine-to-announce-third-quarter-2013-financial-results-and-host-conference-call-on-wednesday-november-6-2013.php"},"modified":"2013-10-30T10:54:30","modified_gmt":"2013-10-30T14:54:30","slug":"bg-medicine-to-announce-third-quarter-2013-financial-results-and-host-conference-call-on-wednesday-november-6-2013","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/bg-medicine-to-announce-third-quarter-2013-financial-results-and-host-conference-call-on-wednesday-november-6-2013.php","title":{"rendered":"BG Medicine to Announce Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013"},"content":{"rendered":"<p><p>      WALTHAM, Mass., Oct. 30, 2013 (GLOBE NEWSWIRE) -- BG      Medicine, Inc. (BGMD)      today announced that the company will host a conference call      and webcast on Wednesday, November 6 at 8:30 a.m. Eastern      Time to discuss its third quarter 2013 financial results. The      call and webcast will follow the release of third quarter      financial results before the market opens.    <\/p>\n<p>      Conference Call Details    <\/p>\n<p>      To access the live conference call on November 6 at 8:30 a.m.      Eastern Time via phone, please dial (877) 845-1016 from the      U.S. and Canada, or (708) 290-1155 internationally. Please      dial in approximately ten minutes prior to the start of the      call.    <\/p>\n<p>      To access the live and subsequently archived webcast of the      conference call, go to the Investor Relations section of the      company's website at       <a href=\"http:\/\/www.bg-medicine.com\" rel=\"nofollow\">http:\/\/www.bg-medicine.com<\/a>. Please connect to the      website at least 15 minutes prior to the call to allow for      any software download that may be necessary.    <\/p>\n<p>      About BG Medicine    <\/p>\n<p>      BG Medicine, Inc. (BGMD)      is a commercial stage company focused on the development and      delivery of diagnostic solutions to aid in the clinical      management of heart failure and related disorders. For      additional information about BG Medicine, heart failure and      galectin-3 testing, please visit       <a href=\"http:\/\/www.bg-medicine.com\" rel=\"nofollow\">http:\/\/www.bg-medicine.com<\/a>. The BG Medicine Inc.      logo is available for download       here    <\/p>\n<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>View post:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/bg-medicine-announce-third-quarter-123000207.html;_ylt=A2KJ3Cd2HXFSlkMA0Sn_wgt.\" title=\"BG Medicine to Announce Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013\">BG Medicine to Announce Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> WALTHAM, Mass., Oct. 30, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD) today announced that the company will host a conference call and webcast on Wednesday, November 6 at 8:30 a.m <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/bg-medicine-to-announce-third-quarter-2013-financial-results-and-host-conference-call-on-wednesday-november-6-2013.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-94226","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/94226"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=94226"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/94226\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=94226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=94226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=94226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}